The Efficacy of Mapping for Cognitive Prostate Biopsy
NCT05902637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175
Last updated 2025-02-25
Summary
Today, many centers still perform Magnetic Resonance Imaging (MRI) cognitive prostate biopsy. The efficacy of detecting clinically significant prostate cancer, which is thought to be due to the experience of the urologist who performed the sampling and the difference in experience of the radiologists who performed the Multiparametric Prostate Magnetic Resonance (MPMR) evaluation, has been reported between 25% and 34% in the literature.
In order to eliminate this reporting and sampling difference, The goal of this interventional study is to compare the effectiveness of Multiparametric Prostate Magnetic Resonance (MPMR) Imaging routinely taken before biopsy with a single-center randomized and prospective study and prostate biopsies to be performed by the same urologist with the mapping technique created by a single genitourinary radiologist working in our center with standard cognitive prostate biopsy and to contribute to the literature Type of study: Clinical trial participant population: Male patients with elevated serum Prostate Specific Antigen (PSA) or indicated prostate biopsy by Magnetic Resonance Imaging (MRI) imaging and underwent Multiparametric Prostate Magnetic Resonance (MPMR) before the procedure Participants will undergo transrectal prostate biopsy with or without mapping, Researches will compare to see if the cancer detection rates differ
Conditions
- Prostate Cancer
- Prostate Adenocarcinoma
- Prostatic Neoplasms
- Prostate Disease
- Prostate Cancer Stage
Interventions
- PROCEDURE
-
Performing cognitive prostate biopsy with a radiologist's guidance with map
All patients will undergo prostate biopsy under local or general anesthesia with transrectal ultrasonography by a single surgeon after mapping extracted by a single genitourinary radiologist in the Department of Radiology of our hospital.
- PROCEDURE
-
Performing cognitive prostate biopsy without a radiologist's guidance with map
All patients will undergo cognitive prostate biopsy under local or general anesthesia with transrectal ultrasonography by a single surgeon after reported by a single genitourinary radiologist in the Department of Radiology of our hospital.
Sponsors & Collaborators
-
Marmara University
lead OTHER
Principal Investigators
-
Haydar Kamil Cam, Prof. · Marmara University, School of Medicine, Department of Urology
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 90 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2024-09-01
- Completion
- 2024-12-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
NCT06612047 ·Status: RECRUITING
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA
-
The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer
NCT06824259 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients
NCT05819606 ·Status: COMPLETED
-
GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies
NCT07258056 ·Status: RECRUITING ·Phase: NA
-
Value of Ultra-fast Prostate MRI in Prostate Cancer
NCT05903781 ·Status: COMPLETED
-
Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial
NCT06362291 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values
NCT01553838 ·Status: COMPLETED ·Phase: NA
-
MRI and Biomarkers in Prostate Cancer
NCT02241122 ·Status: COMPLETED ·Phase: NA
-
Prospective Comparison of the Four Biopsy Methods for Prostate Cancer Detection
NCT05589558 ·Status: COMPLETED ·Phase: NA
-
a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy
NCT05670691 ·Status: UNKNOWN
-
Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis
NCT06392737 ·Status: RECRUITING ·Phase: NA
-
Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed Cognitive Fusion TRUS Guided Prostate Biopsy (PROBIOP)
NCT05137561 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer
NCT05958004 ·Status: COMPLETED
-
68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy
NCT03949517 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA
NCT03187990 ·Status: COMPLETED ·Phase: NA
-
MRI-Ultrasound Fusion or Cognitive Registration in MR-targeted Prostate Biopsy
NCT04953351 ·Status: UNKNOWN ·Phase: NA
-
ReIMAGINE Prostate Cancer Screening
NCT04063566 ·Status: COMPLETED ·Phase: NA
-
Prostate Magnetic Resonance Imaging in Patient With Previous Negative Biopsies
NCT02388126 ·Status: COMPLETED ·Phase: NA
-
Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions
NCT06126172 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures
NCT02936258 ·Status: UNKNOWN ·Phase: NA
-
Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis
NCT06575361 ·Status: COMPLETED ·Phase: NA
-
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
NCT06923657 ·Status: RECRUITING ·Phase: NA
-
68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer
NCT03809078 ·Status: COMPLETED ·Phase: PHASE2
-
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients
NCT05141760 ·Status: COMPLETED ·Phase: PHASE2